Trade Mark Journal No.2021/053 31 December 2021
WO0000001631535 (5)
Office of origin: United States of America
Date of International Registration:10 November 2021
Date of designation in the UK:
10 November 2021

International priority date claimed: 4 November 2021
(United States of America)
(97109149)
- Class 5
- Pharmaceutical preparations for the treatment of chronic fibrotic and proliferative disorders; pharmaceutical preparations for the treatment of cancer, muscular dystrophy and idiopathic pulmonary fibrosis.
FibroGen, Inc.
Representative: Harold Milstein Sheppard Mullin Richter & Hampton LLP, 379 Lytton Avenue, Palo Alto CA 94301, UNITED STATES OF AMERICA